---
title: "Hezong Medicine Easy-To-Buy Pharmaceutical (300937.SZ) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300937.SZ/norm.md"
symbol: "300937.SZ"
name: "Hezong Medicine Easy-To-Buy Pharmaceutical"
parent: "https://longbridge.com/en/quote/300937.SZ.md"
datetime: "2026-05-20T08:16:54.419Z"
locales:
  - [en](https://longbridge.com/en/quote/300937.SZ/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300937.SZ/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300937.SZ/norm.md)
---

# Hezong Medicine Easy-To-Buy Pharmaceutical (300937.SZ) — Financial Reports

## Income Statement (CNY)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.0323 | -0.0431 | -0.0084 | -0.1247 | 0.0437 |
| ROE | -1.33% | -2.18% | -0.36% | -5.60% | 1.96% |
| Revenue | 1.11B | 1.21B | 1.08B | 1.02B | 1.14B |
| Net income | -2.72M | -4.50M | -742068.00 | -11.80M | 4.18M |
| Operating income | 16.61M | 27.36M | 5.63M | 1.41M | 9.85M |
| Gross margin | 10.15% | 8.75% | 11.61% | 10.43% | 11.05% |
| Net margin | -0.24% | -0.37% | -0.07% | -1.16% | 0.37% |
| Profit quality | 23.27% | 27.11% | -5.26% | -3.72% | 32.16% |

## Balance Sheet (CNY)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 1.89B | 1.72B | 1.87B | 1.75B | 1.74B |
| Leverage | 2.36 | 2.16 | 2.27 | 2.14 | 2.07 |
| BVPS | 9.71 | 7.88 | 8.69 | 8.70 | 8.92 |
| Turnover | 2.44 | 2.59 | 2.46 | 2.51 | 2.33 |
| Cash & STI | 445.17M | 409.36M | 361.92M | 336.72M | 350.95M |
| Inv & Rec | 487.54M | 575.19M | 501.68M | 485.90M | 445.48M |
| LT assets | 143.17M | 143.75M | 149.07M | 153.62M | 158.20M |
| Net debt | -99.10M | -71.53M | 14.07M | -18.50M | -11.73M |

## Cash Flow Statement (CNY)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 71.39M | 100.93M | -106.88M | -37.89M | 30.62M |
| Investing CF | -143.02M | 37.97M | -4.85M | -7.15M | -5.03M |
| Financing CF | 36.13M | -74.19M | 93.50M | -12.13M | -87.44M |
| Free CF | 39.95M | 160.77M | -48.82M | 39.11M | 18.10M |
| OCF coverage | 1214.02% | 42.33% | -224.17% | -38.84% | 40.42% |
| Repaid & issued | 39.99M | 159.74M | 145.58M | 85.00M | - |
| CapEx | -4.53M | -515352.00 | -1.46M | -1.84M | -3.75M |

## Distribution Plan

**Dividend Yield**: 0.39

### Dividend History

| Description | Record Date | Ex-Date | Payment Date |
|-------------|-------------|---------|--------------|
| Cash Dividend: 
0.1CNY | 2025-06-12 | 2025-06-13 | 2025-06-13 |
| Cash Dividend: 
0.22CNY | 2024-06-12 | 2024-06-13 | 2024-06-13 |
| Cash Dividend: 
0.2CNY | 2023-05-19 | 2023-05-22 | 2023-05-22 |